We greatly value our faculty's scholarly contributions and are proud to honor their accomplishments.
Corina Schoen, MD
Dr. Corina Schoen, Assistant Director of Obstetric Research at Baystate Medical Center and Assistant Professor of Obstetrics and Gynecology at UMMS-Baystate, published an article in the June 2017 issue of Obstetrics and Gynecology that evaluated whether adding oxytocin to preinduction cervical ripening with a Foley catheter increases the rate of delivery within 24 hours.
“Intracervical Foley Catheter With and Without Oxytocin for Labor Induction: A Randomized Controlled Trial” found that in both nulliparous and multiparous women induction with concurrent oxytocin infusion added to Foley significantly increased the rate of delivery within 24 hours as compared with Foley followed by oxytocin.
Approximately 1 in 5 pregnant women in the United States has her labor induced, and extended periods of labor induction are associated with multiple potential complications for both mother and baby. It is possible that more efficient means of labor induction may be able to reduce the incidence of these adverse events for a large population.
Citation: Schoen, C., Grant, G., Berghella, V., Hoffmann, M., & Sciscione, A. (2017). 43: The intracervical foley catheter with and without oxytocin for labor induction: A randomized trial. American Journal of Obstetrics and Gynecology, 216(1), 31. doi:10.1016/j.ajog.2016.11.012 (Read the Abstract)
Peter Lindenauer, MD
Dr. Peter Lindenauer, Professor of Medicine and Quantitative Health Sciences and Director of the Institute for Healthcare Delivery and Population Science at UMMS-Baystate, was recently awarded a 4.5 year, $3.1M grant from the National Heart, Lung, and Blood Institute at the National Institutes of Health.
“A mixed methods study to analyze the use of pulmonary rehabilitation following hospitalization for COPD and to identify effective strategies for increasing rates of participation” focuses on increasing the use of pulmonary rehabilitation by patients with chronic obstructive pulmonary disease (COPD) following hospital discharge.
Pulmonary rehabilitation—a structured program of exercise, education and support—can increase exercise capacity and quality of life, reduce the risk of hospitalization, and improve survival for the roughly 700,000 people hospitalized with COPD each year in the US. Yet, there is evidence that too few patients take advantage of this treatment option even though it is covered by Medicare. Data also suggest that rates of participation vary widely across hospitals, as do the strategies used to promote patient participation.
Lindenauer and his co-investigators—Drs. Victor Pinto-Plata, Mihaela Stefan and Penny Pekow (UMMS-Baystate), and Kathleen Mazor (UMMS)—will seek to identify the factors and strategies that enable some hospitals to achieve higher rates of participation using statistical analyses of the records of Medicare beneficiaries, site visits and interviews at hospitals with high, low, and improving rates of patient participation and a national survey of hospital practices.
For more information, visit NIH RePORT
Annual Weinberg Award for Academic Excellence
The Weinberg Family Award for Academic Excellence is awarded annually to an individual whose innovative research, publications, or leadership of a national academic organization have brought honor to Baystate Health.
2016 Weinberg Award Winner: Daniel Skiest, MD
Daniel Skiest MD, Chief, Division of Infectious Diseases, has received the 2016 Weinberg Award for Academic Excellence, Baystate Health’s highest academic honor.
Dr. Skiest, Professor of Medicine and director of the Adult HIV/AIDS Programs, has focused his research over his 22 year career on clinical aspects of HIV. In addition to his own research, he has been involved in a number of institutional research-related efforts—the Department of Medicine research task force, the Research Week awards committee, and the Incubator Funds grant committee.
Advancing the Field
When Skiest came to Baystate almost 11 years ago as director of HIV services, part of his mission was to promote clinical research and academic activity.
Since then, he has significantly increased the size and scope of the ID Division, including the establishment of a clinical trials unit with 5 research staff, that has allowed them to offer a number of trials to their patients that they might not otherwise have had access to.
Dr. Skiest and his clinical research team have enrolled over 300 patients in 24 clinical trials in the past 5 years.
They are currently enrolling patients in the NIH-sponsored REPRIEVE trial which is testing the efficacy of statins in people with HIV infection. (More information about the REPRIEVE study) They also participated in the paradigm-changing SMART trial that suggested the superiority of continuous antiviral therapy in treating HIV.
“It’s very exciting to know that you are part of something that could improve the care of your patients and patients everywhere,” says Skiest. “Even to be a small part of that is very gratifying.”
Skiest describes infectious disease as a cognitive sub-specialty, explaining that ID specialists need a wide breadth of knowledge because they are often asked to see the most challenging cases, which usually aren't confined to a single organ system.
Skiest is proud that their ID fellows are being well trained to develop an academic state of mind as well as to be excellent clinicians. He adds that with the challenge of constant new ID threats—Zika, Ebola, SARS—it's imperative that fellows learn to be lifelong learners.
Skiest is particularly gratified to have helped train two fellows who have stayed on as faculty and joined the research team. Armando Paez MD is now the program director of the ID fellowship and Associate Director, Baystate Infectious Diseases Clinical Research. Durane Walker MD is director, Outpatient ID Services and Residency Teaching Coordinator.
"I enjoy teaching, discussing interesting cases. Just by teaching, you are learning a lot."